Abingdon Health Plc (LON:ABDX – Get Free Report) shares were up 0.8% during mid-day trading on Tuesday . The stock traded as high as GBX 8.12 ($0.10) and last traded at GBX 8.06 ($0.10). Approximately 249,014 shares traded hands during mid-day trading, an increase of 82% from the average daily volume of 136,705 shares. The stock had previously closed at GBX 8 ($0.10).
Abingdon Health Price Performance
The stock has a market capitalization of £15.28 million, a PE ratio of -899.00 and a beta of 0.13. The company has a debt-to-equity ratio of 46.64, a current ratio of 1.95 and a quick ratio of 1.96. The stock’s fifty day moving average is GBX 7.61 and its 200-day moving average is GBX 9.
Abingdon Health Company Profile
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.
Featured Stories
- Five stocks we like better than Abingdon Health
- With Risk Tolerance, One Size Does Not Fit All
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- What is Short Interest? How to Use It
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Stock Market Sectors: What Are They and How Many Are There?
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.